Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/27/2009 | US20090214762 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes in fluids |
08/27/2009 | US20090214655 Method and Device for Obtaining Micro and Nanometric Size Particles |
08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
08/27/2009 | US20090214636 Imaging and Therapeutic Method Using Monocytes |
08/27/2009 | US20090214612 Extracellular tnf inhibitors for treating cns disorders |
08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
08/27/2009 | US20090214584 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
08/27/2009 | US20090214573 Modulation of bne development |
08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
08/27/2009 | US20090214571 Colon cancer related gene tom34 |
08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
08/27/2009 | US20090214557 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
08/27/2009 | US20090214556 Antibodies and related molecules that bind to 161p2f10b proteins |
08/27/2009 | US20090214553 Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells |
08/27/2009 | US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
08/27/2009 | US20090214548 TGR3-Like Protein Receptor |
08/27/2009 | US20090214547 Binding member towards pneumolysin |
08/27/2009 | US20090214546 Novel therapeutic targets in cancer |
08/27/2009 | US20090214542 Novel therapeutic targets in cancer |
08/27/2009 | US20090214540 Protein involved in cancer |
08/27/2009 | US20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment |
08/27/2009 | US20090214535 Pharmaceutical Compositions Containing sc(Fv)2 |
08/27/2009 | US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons |
08/27/2009 | US20090214531 Methods and Compositions for Treating and Preventing Bacterial Infections |
08/27/2009 | US20090214525 Novel anti-igf-ir antibodies and uses thereof |
08/27/2009 | US20090214523 Novel anti-IL13 antibodies and uses thereof |
08/27/2009 | US20090214520 Soluble CLCA-1 and antagonists to CLCA-1 |
08/27/2009 | US20090214519 Compositions and Methods for Treating Inflammation |
08/27/2009 | US20090214518 Methods and compositions for treating solid tumors and enhancing tumor vaccines |
08/27/2009 | US20090214516 Inhibitors of Reglll Proteins as Asthma Therapeutics |
08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
08/27/2009 | US20090214514 Gus3 neuropeptides for regulating hypothalamic function |
08/27/2009 | US20090214490 Human embryonic stem cell methods and podxl expression |
08/27/2009 | US20090214477 Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis |
08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
08/27/2009 | US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof |
08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
08/27/2009 | US20090214430 Polypeptide specifically bound to phosphatidylserine and the use thereof |
08/27/2009 | US20090214426 Assay Method |
08/27/2009 | US20090214424 Human glycoprotein hormone superagonists and uses thereof |
08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
08/27/2009 | US20090214101 Targeted Nanostructures for Cellular Imaging |
08/27/2009 | US20090213360 Device and method for in vitro determination of analyte concentration within body fluids |
08/27/2009 | US20090212663 Electronic tongue sensor |
08/27/2009 | US20090211923 Sensors |
08/27/2009 | US20090211437 Apparatus and Method for increasing the selectivity of fet-based gas sensors |
08/27/2009 | US20090211345 Method for the detection of lateral flow assay and strip and laser-induced epifluorescence and compact scanner therefor |
08/27/2009 | US20090211344 Analyte sensors and methods of use |
08/27/2009 | US20090211342 Method for the Quantitative Determination of an Aging Effect on Motor Oil |
08/27/2009 | US20090211333 Sensor assembly having a flow head |
08/27/2009 | DE202009008632U1 Medizinisches Vorsorgekit Medical Vorsorgekit |
08/27/2009 | DE202007018852U1 Produkt aus einem Serum Product of a serum |
08/27/2009 | DE102008055143A1 Method for technical detection of printing color characteristic value at printing machine, involves employing running roller at color deck roller of color deck of printing unit of printing machine |
08/27/2009 | DE102008007956A1 Fluid sample e.g. breathable air of patient, removing method for fluid system, involves automatically removing predetermined sample quantity from system by control device, when predetermined threshold exceeds or falls below system condition |
08/27/2009 | DE102008006815A1 Organic material's e.g. organic residual waste, maturation degree determining method, involves determining characteristics of oxygen content over measuring period, and deriving maturation degree of sample from characteristics |
08/27/2009 | DE102008003190A1 Detecting mold fungus infestation spot, comprises measuring typical markers of molds i.e. its metabolic products, and operating high resolution portable ion mobility spectrometer into suspicion room analysis of room air on the spot |
08/27/2009 | DE102008000372A1 Exhaust gas measuring device for internal combustion engine, has exhaust sensor arranged such that gas outlet of protective pipe leads directly into output channel of flow sampling component |
08/27/2009 | DE102008000292A1 Röhrenförmiger Multifunktionssensor in Flüssigkeiten, Verfahren zu seiner Herstellung und Verwendung A tubular multi-function sensor in liquids, process for its preparation and use |
08/27/2009 | CA2752838A1 Cell processing and/or enrichment methods |
08/27/2009 | CA2720747A1 Substrates for multiplexed assays and uses thereof |
08/27/2009 | CA2717690A1 Brca1 mrna expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy |
08/27/2009 | CA2717670A1 Brca1 mrna expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy |
08/27/2009 | CA2716280A1 Biomarkers |
08/27/2009 | CA2716251A1 Tissue sample preprocessing methods and devices |
08/27/2009 | CA2716204A1 Assay method for antibodies against cyclic citrullinated peptide |
08/27/2009 | CA2716074A1 Method and device for detection of an analyte |
08/27/2009 | CA2716049A1 Methods and compositions for diagnosis of age-related macular degeneration |
08/27/2009 | CA2716027A1 Method for early determination of recurrence after therapy for prostate cancer |
08/27/2009 | CA2715940A1 Oligopeptidic compounds and uses thereof |
08/27/2009 | CA2715676A1 Mucosal membrane receptor and uses thereof |
08/27/2009 | CA2713645A1 Slit2 cancer markers |
08/27/2009 | CA2713421A1 Covalently linked thermostable kinase for decontamination process validation |
08/27/2009 | CA2712204A1 Small cell lung carcinoma biomarker panel |
08/26/2009 | EP2093570A1 Modulating the interaction between HGF beta chain and c-met |
08/26/2009 | EP2093569A2 Compositions and methods for quantification of serum glycoproteins |
08/26/2009 | EP2093568A1 Brca1 mRNA expression predicts survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy |
08/26/2009 | EP2093567A1 Brca1 mRNA expression levels predict survival in breast cancer patients treated with neoadjuvant chemotherapy |
08/26/2009 | EP2093566A1 Method for the prognosis of non-small cell lung cancer |
08/26/2009 | EP2093565A2 Substrates, devices, and methods for cellular assays |
08/26/2009 | EP2093564A1 Method for distinguishing secretory granules of different ages |
08/26/2009 | EP2093297A2 Agents for treatment or prevention of an allergic disorder |
08/26/2009 | EP2093296A2 Electrode with thin working layer |
08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
08/26/2009 | EP2093293A2 G-Protein coupled receptors |
08/26/2009 | EP2093289A1 Knockout animal exhibiting anxiety-like behavior |
08/26/2009 | EP2093287A1 Igg-binding peptide |
08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
08/26/2009 | EP2093194A1 Fluorescent labeling agent and fluorescent labeling method |
08/26/2009 | EP2092939A2 Therapeutical use of antibody inducing the production of cytokines |
08/26/2009 | EP2092938A1 Survivin-derived peptides and use thereof |
08/26/2009 | EP2092344A2 Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female |
08/26/2009 | EP2092343A1 Detection conjugate |
08/26/2009 | EP2092341A1 Enzyme detection techniques |
08/26/2009 | EP2092340A1 Measuring multiple analytes over a broad range of concentrations using optical diffraction |
08/26/2009 | EP2092339A2 Microelectronic sensor device for detecting label particles |
08/26/2009 | EP2092338A1 Biotechnological device including an actuation means for changing the mobility of preselected biomolecules |
08/26/2009 | EP2092337A1 Biotechnological device including a structured hydrogel permeation layer |
08/26/2009 | EP2092336A1 Capture of mycobacteria like micro-organisms |